• Human Cortical Interneurons for Durable Seizure Control

  2026-09-03

  Zhu et al. show that chemically matured human cortical interneurons can integrate specifically into epileptic circuits, suppress seizures over prolonged periods, and improve associated behavioral deficits without evidence of uncontrolled growth or increasing host over-inhibition. Their combination of density testing, closed-loop optogenetics, and monosynaptic tracing provides a mechanistic framework for evaluating cell-based epilepsy therapies.

• TPPU: Soluble Epoxide Hydrolase Inhibitor Workflows

  2026-09-03

  TPPU enables controlled interrogation of fatty acid epoxide signaling across cell, lipidomic, inflammatory pain, and bone-remodeling assays. This workflow-centered guide connects nanomolar sEH inhibition with practical controls for osteoclastogenesis, 14,15-EET biology, and chronic inflammation research.

• Losartan: AT1 Blockade in Vascular Research

  2026-09-02

  Losartan is a selective angiotensin II receptor antagonist used to dissect AT1-dependent vascular signaling and blood-pressure mechanisms. Its defined receptor activity, reported approximately 20 nM binding-inhibition IC50, and compatibility with vascular assays make it a practical tool for hypertension research when vehicle controls and model-specific validation are included.

• Angiotensin II–Driven Radioresistance in NPC

  2026-09-02

  The reference study shows that local angiotensin II promotes nasopharyngeal carcinoma radioresistance by suppressing ferroptosis through an AGT–HIF-1α–HILPDA regulatory circuit. Its combination of molecular, cellular, tissue, and xenograft evidence supports angiotensin receptor blockade plus ferroptosis induction as a radiosensitization strategy, while also identifying candidate biomarkers for response and prognosis.

• GDC-0994: Reading ERK Signals Across Models

  2026-09-01

  GDC-0994 is a selective ERK1/2 inhibitor for connecting pathway engagement with cancer-cell phenotypes and cholestatic liver injury. This article translates mechanistic evidence into model-specific assay decisions rather than repeating a conventional workflow guide.

• CHIR-99021 and Axonogenesis: An Assay-Design Guide

  2026-09-01

  CHIR-99021 and CT99021 offer precise GSK-3 control for stem cell and neuronal studies. This guide connects pathway activation with the time-resolved RNA, protein, and imaging assays needed to interpret axon formation without confusing transcriptional induction with functional protein accumulation.

• HotStart Universal 2X Green qPCR Master Mix Guide

  2026-08-31

  Build a reproducible dye-based qPCR workflow for FGFR2 fusion research, from RNA quality control and primer design through melt curve confirmation. This practical guide shows how hot-start Taq polymerase, Green I fluorescence, and ROX normalization can support gene expression quantification in cholangiocarcinoma models while highlighting assay limits and troubleshooting decisions.

• Vemurafenib Workflows for Melanoma Resistance

  2026-08-31

  Vemurafenib (PLX4032) provides a controlled way to interrogate BRAF V600E signaling, melanoma cell proliferation inhibition, and adaptive drug resistance. This research workflow connects dose-response assays with phospho-signaling and multi-omics designs, helping distinguish true pathway dependence from paradoxical RAF activation.

• Phosbind Acrylamide: Workflow and Troubleshooting

  2026-08-30

  Phosbind Acrylamide enables phosphate-dependent mobility shifts in SDS-PAGE, offering an antibody-sparing route to compare phosphorylated and non-phosphorylated proteins. This practical workflow connects the reagent to SepM–ComDE signaling research while emphasizing controls, gel preparation, and troubleshooting limits.

• DiscoveryProbe Natural Product Library Plus Workflow

  2026-08-29

  Turn a diverse natural product library into a disciplined path from primary enzyme inhibition to cell-based validation. This workflow uses the DiscoveryProbe™ Natural Product Library Plus to support reproducible HTS, orthogonal confirmation, and mechanism-aware hit triage for challenging targets such as Cryptosporidium parvum AdhE.

• Bifendate (DDB): Liver Assay Workflows

  2026-08-28

  Bifendate (DDB) combines hepatoprotection research with mechanistic control of lysosomal autophagy and lipid-droplet accumulation. This practical guide translates the reference study into cell-based workflows, animal-study planning, assay controls, and troubleshooting strategies.

• ERK5, Vitamin D, and Myeloid Leukemia Differentiation

  2026-08-28

  The reference study separates the roles of ERK5 and ERK1/2 in 1α,25-(OH)2 vitamin D3-induced differentiation of AML cell lines. Its key contribution is showing that ERK5 inhibition changes differentiation-marker patterns while also producing cell-cycle arrest, particularly in G2, providing a mechanistic basis for combining vitamin D derivatives with ERK5-directed strategies.

• SB 431542 for TGF-β EndMT Studies

  2026-08-27

  Use SB 431542 as a selective ALK5 inhibitor to test whether TGF-β receptor activity drives PM2.5-induced endothelial–mesenchymal transition. This workflow combines Smad phosphorylation, endothelial and mesenchymal markers, lncRNA analysis, migration, and proliferation readouts for stronger mechanistic conclusions.

• Estramustine Compliance in Very High-Risk Prostate Cancer

  2026-08-27

  This prospective study found that reduced estramustine phosphate exposure during six-month neoadjuvant chemohormonal therapy with degarelix acetate was associated with inferior biochemical recurrence-free survival in very high-risk prostate cancer. Its main contribution is to identify treatment compliance, alongside disease-risk category, as a clinically informative factor while highlighting substantial toxicity and the limits of causal interpretation.

• Fingolimod (FTY720) and Immune Trafficking

  2026-08-26

  Fingolimod (FTY720) offers translational researchers a controllable way to study S1P-regulated lymphocyte trafficking, CNS signaling, and the design constraints of emerging in vivo CAR-T-mimicking platforms.

8629 records 1/576 page Next 12345 下5页 Last page